Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

• Status: Terminated
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Multiple forms of Omega-3 Fatty acids have been used to investigate the role of this food supplement in children with Attention Deficit Hyperactivity Disorder (ADHD). No clear evidence for their role in this disorder is yet available. We will conduct a prospective, randomized, double blind, placebo controlled trial to obtain significant results regarding this question.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maimonides Medical Center
• Collaborator: GlaxoSmithKline
• Treatments: Central Nervous System Stimulants

Criteria

Inclusion Criteria:

• Male and female Children 6 to 15 years old

• Diagnosis of ADHD according to the DSM IV -TR

Exclusion Criteria:

• Children younger than 6 y/o or older than 15 y/o

• Children with other co-morbid disorders according to the DSM IV-TR

• Mentally retarded children

• Poor compliance with treatment

• Children with a diagnosis of blood clotting problems

• Children on anticoagulants

• Children with hypersensitivity to fish

• Children "In care" (CiC): Foster children or children that are not being taken care of by a biological parent or a legal guardian.

• Children who follow a kosher diet (Lovaza is not kosher)

• Pregnancy